Suppr超能文献

重新定义禁水-加压素试验的诊断临界值。

Redefining Diagnostic Cut-Offs for the Indirect Water Deprivation Test.

作者信息

Akkara Yash, Narula Kavita, Lazarus Katharine, Papadopoulou Deborah, Choudhury Sirazum, Martin Niamh, Meeran Karim

机构信息

Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism Digestion and Reproduction, Imperial College London, London, UK.

Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

出版信息

Clin Endocrinol (Oxf). 2025 Feb;102(2):149-155. doi: 10.1111/cen.15172. Epub 2024 Dec 5.

Abstract

OBJECTIVE

An incorrect diagnosis of arginine vasopressin deficiency and resistance (AVP-D and AVP-R) results in the potentially dangerous use of desmopressin in healthy individuals. The water deprivation test is a central diagnostic test in patients with polydipsia polyuria syndrome (PPS). This study aims to determine the effectiveness of the current interpretation of reference ranges.

METHODS

This is a retrospective analysis of 135 patients who underwent a water deprivation test between August 2014 and August 2023. All patient diagnoses were reviewed, and variability and receiver operating characteristic (ROC) curves were determined for serum osmolality, serum sodium and urine osmolality.

RESULTS

Serum sodium demonstrated reduced variability compared with serum osmolality (0.72% vs. 1.16%, respectively, 37.5% reduction; p < 0.001). The standard serum osmolality cut-off value of ≥ 300 mOsm/kg in diagnosing AVP-D, AVP-R, and primary polydipsia (PP) achieved a sensitivity of 76.19% and specificity of 76.92%. A serum sodium cut-off value of ≥ 148 mmol/L demonstrated 100% specificity in excluding PP. This cut-off was used alongside urine osmolality cut-off values of > 630 mOsm/kg (for PP) and < 383 mOsm/kg (for AVP-D/AVP-R). Review of post-desmopressin urine osmolality and clinical monitoring was performed in equivocal diagnostic cases (n = 6), achieving 100% sensitivity and 100% specificity within the study sample.

CONCLUSIONS

This study demonstrates that a serum sodium cut-off of ≥ 148 mmol/L in tandem with urine osmolality yields the best diagnostic accuracy to differentiate between AVP-D, AVP-R, and PP. Serum sodium may be more reliable than serum osmolality in the investigation of patients with PPS, demonstrating lower biological and analytical variability.

摘要

目的

精氨酸血管加压素缺乏和抵抗(AVP-D和AVP-R)的错误诊断会导致在健康个体中潜在危险地使用去氨加压素。禁水试验是多饮多尿综合征(PPS)患者的核心诊断试验。本研究旨在确定当前参考范围解读的有效性。

方法

这是一项对2014年8月至2023年8月期间接受禁水试验的135例患者的回顾性分析。回顾了所有患者的诊断,并确定了血清渗透压、血清钠和尿渗透压的变异性及受试者操作特征(ROC)曲线。

结果

与血清渗透压相比,血清钠的变异性降低(分别为0.72%和1.16%,降低了37.5%;p < 0.001)。在诊断AVP-D、AVP-R和原发性烦渴(PP)时,标准血清渗透压临界值≥300 mOsm/kg的灵敏度为76.19%,特异性为76.92%。血清钠临界值≥148 mmol/L在排除PP方面显示出100%的特异性。该临界值与尿渗透压临界值>630 mOsm/kg(用于PP)和<383 mOsm/kg(用于AVP-D/AVP-R)一起使用。对诊断不明确的病例(n = 6)进行了去氨加压素后尿渗透压回顾和临床监测,在研究样本中实现了100%的灵敏度和100%的特异性。

结论

本研究表明,血清钠临界值≥148 mmol/L与尿渗透压相结合可产生最佳诊断准确性,以区分AVP-D、AVP-R和PP。在PPS患者的调查中,血清钠可能比血清渗透压更可靠,显示出更低的生物学和分析变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad63/11694560/e5edba864dde/CEN-102-149-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验